1. Home
  2. DARE vs AIDX Comparison

DARE vs AIDX Comparison

Compare DARE & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$3.24

Market Cap

21.6M

Sector

Health Care

ML Signal

HOLD

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$1.49

Market Cap

19.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DARE
AIDX
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
19.5M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
DARE
AIDX
Price
$3.24
$1.49
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
826.4K
55.1K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,807,885.00
N/A
Revenue This Year
$2,115.12
N/A
Revenue Next Year
$122.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$1.45
52 Week High
$9.19
$14.09

Technical Indicators

Market Signals
Indicator
DARE
AIDX
Relative Strength Index (RSI) 71.99 23.23
Support Level $1.79 $1.51
Resistance Level $3.43 $2.08
Average True Range (ATR) 0.39 0.14
MACD 0.04 0.10
Stochastic Oscillator 88.91 27.50

Price Performance

Historical Comparison
DARE
AIDX

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: